Belite Bio (BLTE) Shares Issued (2021 - 2025)

Belite Bio's Shares Issued history runs 5 years deep, the most recent figure standing at $23829.0 for Q4 2025.

• On a quarterly basis, Shares Issued fell 99.54% year-over-year to $23829.0 in Q4 2025; TTM through Dec 2025 was $23829.0, a 99.54% decrease from a year earlier, with the FY2025 full-year figure at $23829.0, down 99.54% from the prior year.
• Shares Issued slipped to $23829.0 in Q4 2025 per BLTE's latest filing, from $5.1 million in the prior quarter.
• Across five years, Shares Issued topped out at $5.1 million in Q4 2024 and bottomed at $23829.0 in Q4 2025.
• The 5-year median for Shares Issued is $3.6 million (2022), against an average of $3.0 million.
• Across the five-year window, Shares Issued surged 80.39% in 2022 and tumbled 99.54% in 2025, its largest moves.
• Year by year, Shares Issued stood at $2.0 million in 2021, then jumped by 80.39% to $3.6 million in 2022, then advanced by 17.49% to $4.2 million in 2023, then advanced by 22.09% to $5.1 million in 2024, then tumbled by 99.54% to $23829.0 in 2025.
• Per Business Quant, the three latest BLTE Shares Issued figures stand at $23829.0 (Q4 2025), $5.1 million (Q4 2024), and $4.2 million (Q4 2023).